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ABSTRACT 
The aim of this study was to determine the relationships between subclinical mastitis and milk arginase 
activity in dairy cows. Thirty, various breed 4-8 year old cows from Firat University Animal Hospital were 
used in the study. Subclinical mastitis was diagnosed by the California Mastitis Test (CMT) combined with 
bacteriological examination of milk samples. The subclinical mastitis group consisted of fi fteen clinically 
healthy but CMT and microbiologically positive animals. CMT and microbiologically negative animals (n = 
15) served as the control group. Arginase activity in milk samples was measured by spectrophotometer using 
the thiocemicarbazide diacetylmonoxime urea (TDMU) method and protein was determined with the folin 
phenol reagent. Arginase activity in the milk of animals with subclinical mastitis (0.26 ± 0.07 U/mg protein) 
signifi cantly increased compared to the arginase activity in the milk from healthy animals in the control group 
(0.10 ± 0.03 U/mg protein). Milk enzyme activity in the mildly severe disease (0.26 ± 0.01 U/mg protein) 
was signifi cantly lower than in the moderately severe disease (0.30 ± 0.01 U/mg). No relationship was found 
between the nature of the bacterial infection of the cows with subclinical mastitis and their milk arginase 
activity. It was concluded that assay of milk arginase activity may be used as an additional laboratory method 
for the diagnosis of subclinical mastitis.
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Introduction
Mastitis is the infl ammation of all structures forming the mammary tissue and the 
surrounding connective tissue. The disease is the reaction of the mammary gland to 
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irritants and signifi cantly infl uences the quality and quantity of mammary tissue and milk 
(YÜKSEL et al., 2009). Mastitis has various underlying causes and degrees of severity, 
with subclinical mastitis being the most widely encountered form. A decrease in milk 
production and a reduction in milk quality are seen in subclinical mastitis, without signs 
of macroscopic infl ammation or visible changes in the milk (YAGCI, 2008; JAIN et al., 
2012). The disease results in changes in the composition of milk and shortening of the 
productive lives of cows. About 70-80% of mastitis-induced milk production losses 
originate from subclinical mastitis (GURBULAK et al., 2009). 
In subclinical mastitis, some changes may be observed in the milk, including the 
increased presence of plasma proteins, changes in ion concentration, a reduction in the 
synthesis capacity of the mammary epithelium, the passage of intracellular components to 
the milk due to the destruction of local cells, and an increase in somatic cells (SANDHOLM 
and MATILLA, 1986). The fi rst pathological change seen in animals with mastitis is the 
passage of albumin from the blood to the milk. Sodium, chloride and bicarbonate passage 
also increases, with subsequent changes in the pH of the milk (ALACAM, 1990). The 
concentration of milk histamine and glycogen content are higher than in healthy milk. The 
increase in the number of leucocytes results in an increased glycogen content. Enzymes 
associated with infl ammation reaction increase during the infl ammation (YAGCI, 2008).
Arginase (E.C. 3.5.3.1, L- arginine-amidino hydrolase) is the fi nal enzyme of the 
urea cycle (KANDEMIR and OZDEMIR, 2009). Catalyzing the hydrolysis of L-arginine to 
ornitine and urea, arginase has two isoforms. While arginase I is localized in the cytoplasm, 
arginase II is found in the mitochondria (KEPKA-LENHART et al., 2008). Although the urea 
cycle is present only in hepatocytes, the arginase enzyme is seen in many other cells. The 
liver has the highest content and it is active in the urea cycle to transform ammonia to 
non-toxic components (SPEKTOR et al., 1982; FUENTES et al., 1994; BER and MUSZYNSKA, 
1979). It has been reported to be present at low concentrations in many tissues, such as the 
kidneys, brain, intestines and the mammary gland, and serves special functions, such as 
polyamine synthesis and the production of the proline required for protein biosynthesis, 
in addition to its functions in the urea cycle (OZCELIK and OZDEMIR, 2003). BASCH et al. 
(1997) suggested proline synthesis in the mammary gland, where it has been reported to 
synthesize the amino acid proline required for casein synthesis.
It has been found that arginase has many metabolic functions and plays an important 
role in certain diseases (KANDEMIR and OZDEMIR, 2009), and arginase activity increases 
in infl ammatory processes (BACHETTI et al., 2004). The purpose of this study was to study 
the relationship between subclinical mastitis and milk arginase activity, and investigate 
the value of milk arginase activity in the diagnosis of subclinical mastitis.
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Materials and methods
Animal and clinical examination. The study material consisted of 30 cows of varying 
breeds, aged between 4 and 8 years, admitted to the Obstetrics and Gynecology Clinic of 
the Animal Hospital, Faculty of Veterinary Medicine, Fırat University. Samples of milk 
were collected from all mammary quarters of the cow for the California Mastitis Test 
(CMT), and for bacteriological examinations 5 mL of milk samples were collected in 
sterile tubes, observing asepsis-antisepsis rules. Animals with no clinical changes in their 
milk, but positive for CMT and/or found be bacteriologically positive, were classifi ed as 
having subclinical mastitis (n = 15), whereas those who were CMT and bacteriologically 
negative formed the control group (n = 15).
Enzyme assay. The milk samples collected were centrifuged for 15 minutes at 
15000 g. The fat layer was removed and the supernatant portion was used for assay. 
Milk arginase activity was measured by spectrophotometer, using a modifi cation of the 
thiosemicarbazide-diacetylmonoxime urea (TDMU) method, described by GEYER and 
DABICH (1971). Measurements were made in duplicate. 
Briefl y, 0.1 mL of supernate was diluted with 2 mM MnCl2 at the rate of 1:10 (v/v), 
and preincubated for 14 minutes at 58 °C. Tubes containing 0.3 mL enzyme source, 0.3 
mL L-arginine (120 mM, pH 9.5) and 0.4 mL carbonate buffer (200 mM, pH 9.5) were 
incubated for 10 minutes at 37 °C. The reaction was stopped by adding 3 mL acid reagent, 
and 2 mL color reagent was added to the tubes, which were kept in the water bath for 
10 minutes. Then tubes were taken from the water bath, cooled, and their absorbance 
was measured at 520 nm. The principle of arginase activity determination was based 
on spectrophotometric measurement of urea produced by hydrolysis of L-arginine by 
arginase. One unit of arginase activity was expressed as the amount of enzyme catalyzing 
the formation of one micromole of urea/h at 37 °C. The results (specifi c activity) were 
presented as units/mg protein.
The protein concentration was determined by the method of LOWRY et al. (1951), 
using bovine serum albumin as standard. Briefl y, tubes including 1 mL alkaline copper 
reagent and 0.1 mL supernatant samples were mixed and incubated for 10 minutes at 
room temperature. Following this, 4 mL of the folin and Ciocalteu’s phenol reagent were 
added to the tubes, and mixed and incubated for 5 min at 55 °C. The absorbance of the 
samples was measured at 650 nm using a Shidmadzu UV 240 spectrophotometer. 
Statistical analyses. Data were analyzed statistically by analysis of variance 
(ANOVA). Differences between the means were statistically estimated by the Independent 
Sample T Test. All values were expressed as mean and standard error of the mean (SEM). 
Statistical signifi cance was judged at a signifi cant level of P<0.05. 
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Results
Among the subclinically infected animals, 8 cows had staphylococcus infection, 
while streptococcus infection was revealed in 7 cows. The mean milk arginase activity 
in healthy animals (Table 1) was 0.10 ± 0.03 U/ mg protein, while cows with subclinical 
mastitis showed a mean value of 0.26 ± 0.07 U/mg protein in milk (P<0.01).
Table 1. Milk arginase activities (mean ± SEM) of subclinical mastitis and healthy cows
Parameter Mastitis Group Control Group P
Milk arginase activity (U/mg protein) 0.26 ± 0.07 0.10 ± 0.03 <0.01
An examination of milk arginase activity by the severity of mastitis (Table 2) showed 
that the enzyme activity was 0.26 ± 0.01 U/mg protein at mild (++), increasing up to a 
concentration of 0.30 ± 0.01 for cows with moderate severity (+++). There was a positive 
correlation (P<0.05) between the severity of the mastitis and milk arginase activity.






Milk arginase activity 
(U/mg protein) 0.26 ± 0.01 0.30 ± 0.01 <0.05
No correlations (P>0.05) were found between the species of bacteria in milk and 
enzyme activity (Table 3).
Table 3. Relationships between bacterial species and milk arginase activity.
Parameter
Staphylococcus aureus
(n = 8) 
Streptococcus agalactiea
(n = 7) P
Milk arginase activity 
(U/mg protein) 0.30 ± 0.16    0.29 ± 0.10    >0.05
Discussion 
The early diagnosis and appropriate treatment of mastitis are recommended as 
solving one of the major problems of dairy farming which causes signifi cant economical 
losses (SMITH, 1983). For this reason much research has been done into the early 
diagnosis and treatment of the condition. Currently, direct methods such as microscopic 
somatic cell count (SCC), fossomatic and Coulter Counter are commonly used, as well 
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as indirect methods such as: the California Mastitis Test, White Side Test, Catalase Test 
and Wisconsin Mastitis Tests (ANONYM., 1981). Measurement of the milk’s electrical 
conductivity and microbiological examinations are also methods used in diagnosing 
subclinical mastitis (YAGCI, 2008) and the biochemical changes caused by this disease 
in the blood and body fl uids can be detected using various laboratory tests (KITCHEN et 
al., 1980). Today, biochemical analyses are one of the most commonly used methods for 
following the course of a disease. The determination of the disease’s impacts, particularly 
on the biochemical parameters in the blood and serum, has an important role in the 
treatment of the disease and in the use of protective and control measures for this disease 
(ALTUNTAS and FIDANCI, 1993). 
Many biochemical studies had been conducted on cows with subclinical mastitis and 
different enzyme activities analyzed to assist the diagnosis process. Lactate dehydrogenase 
(LDH), N-acetyl-β-D glucosaminidase (NAGase) and alcaline phosphatase (ALP) 
are some of the enzymes used for diagnosis of mastitis (NIZAMLIOGLU et al., 1989; 
NIZAMLIOGLU et al., 1992). 
ALP and alanine aminotransferease (ALT) enzyme activities were studied in both 
the blood serum and the milk in animals with subclinical mastitis, and efforts were 
made to associate these enzymes with the condition (YÜKSEL et al., 2009; CETIN et al., 
2005; BATAVANİ et al., 2003; NAK, 1999; ATROSHI et al., 1996; MERT et al., 1992). It was 
determined that ALP synthesis from the damaged cells was increased (TURGUT, 2000). 
MERT et al. (1992) and WADA et al. (2002) reported that the serum ALP activity was higher 
in animals with mastitis than in healthy animals. The serum and milk activity of ALP was 
found to be 15 times higher in animals with mastitis compared to controls and 6 times 
higher in the case of ALT activity (TRIPATHI, 2000). N-acetyl β-D glicosaminidase, a 
lysosomal enzyme have been found to be an indicator of tissue destruction, and although 
its role in the mammary gland remains unknown, it was found to be synthesized at an 
increased level during mastitis (YAGCI, 2008), with reports of a positive correlation 
between the enzyme activity in milk and CMT fi ndings (NIZAMLIOGLU et al., 1992). It 
was also found that the lactate dehydrogenase (LDH) enzyme was a determining enzyme 
in the diagnosis of mastitis, and that the LDH level in milk with mastitis was 3 times 
higher than that in the serum of normal animals, and 16 times higher than in normal milk 
(BOGIN and ZIV, 1973).
In the present study, we focused on the arginase activity in milk and found that the 
arginase activity in milk with subclinic mastitis was about 2.5 times higher than the 
arginase activity in the control group. Although arginase enzyme is known to be present in 
the mammary gland (OZCELIK and OZDEMIR, 2003; BASCH et al., 1997), no studies have 
been undertaken of changes in the enzyme activity in milk under different circumstances. 
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L-Arginin is metabolized to nitric oxide by the nitric oxide synthase enzyme and is 
also metabolized to urea and ornitine by the arginase (COOK et al., 1994). In infl ammatory 
cases, these two pathways compete with each other. Arginase is also present in the region 
of infl ammation. It is stated that arginase functions play a role in regulating apoptosis in 
the infl ammatory region, and produce structural and cellular proteins (WADDINGTON and 
CATTELL, 2002). Arginase is necessary for production of polyamines and proline, which 
are required for cell proliferation and matrix production (WADDINGTON et al., 1998).
Arginase contributes to the healing process, because NO formation is suppressed by 
an increase in the arginase activity in the infl ammatory region. It is proposed that arginase 
passes into the milk in the event of mammary gland infl ammation, with a subsequent rise 
in milk arginase activity. This may be of importance in the diagnosis of subclinic mastitis. 
This study concludes that milk arginase activity may be used as an additional laboratory 
method for the diagnosis of subclinical mastitis.
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SAŽETAK
Cilj istraživanja bio je utvrditi povezanost između supkliničkog mastitisa i aktivnosti arginaze u mlijeku 
krava. U istraživanje je uključeno 30 krava u dobi od 4 do 8 godina. Krave su bile različitih pasmina i pacijenti 
bolnice Firat Sveučilišta. Supklinički mastitis dijagnosticiran je kombinacijom kalifornijskog mastitis testa 
(KMT) i bakteriološke pretrage uzoraka mlijeka. Skupinu sa supkliničkim mastitisom činilo je 15 klinički 
zdravih krava pozitivnih pretragom s KMT i bakteriološki pozitivnim nalazom. Petnaest krava s pozitivnim KMT 
i bakteriološki negativnim nalazom poslužilo je kao kontrolna skupina. Aktivnost arginaze u uzorcima mlijeka 
utvrđena je spektrofotometrijski, uz primjenu tiocemikarbazid diacetilmonoksim ureja metode (TDMU), a 
bjelančevine su bile određene pomoću folin fenol reagensa. Aktivnost arginaze u mlijeku krava sa supkliničkim 
mastitisom (0,26 ± 0,07 U/mg bjelančevina) bila je značajno povišena u usporedbi s uzorcima iz mlijeka zdravih 
krava kontrolne skupine (0,10 ± 0,03 U/mg bjelančevina). U krava sa slabo izraženim simptomima bolesti, 
aktivnost enzima u mlijeku (0,26 ± 0,01 U/mg protein) bila je značajno niža u odnosu na krave s umjerenim 
simptomima (0,30 ± 0,01 U/mg). Nije utvrđena povezanost između prirode bakterijske infekcije i supkliničkog 
mastitisa odnosno aktivnosti arginaze u mlijeku. Zaključak je da analiza aktivnosti arginaze može poslužiti kao 
dodatna laboratorijska metoda za dijagnostiku supkliničkog mastitisa. 
Ključne riječi: supklinički mastitis, arginaza, krave, kalifornijski mastitis test________________________________________________________________________________________
